Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Am J Physiol Renal Physiol
2008 Aug 01;2952:F371-9. doi: 10.1152/ajprenal.00090.2008.
Show Gene links
Show Anatomy links
A novel missense mutation in SLC34A3 that causes hereditary hypophosphatemic rickets with hypercalciuria in humans identifies threonine 137 as an important determinant of sodium-phosphate cotransport in NaPi-IIc.
Jaureguiberry G
,
Carpenter TO
,
Forman S
,
Jüppner H
,
Bergwitz C
.
???displayArticle.abstract???
The present study describes two novel compound heterozygous mutations, c.410C>T(p.T137M) (T137M) on the maternal and g.4225_50del on the paternal allele of SLC34A3, in a previously reported male with hereditary hypophosphatemic rickets with hypercalciuria (HHRH) and recurrent kidney stones (Chen C, Carpenter T, Steg N, Baron R, Anast C. Pediatrics 84: 276-280, 1989). For functional analysis in vitro, we generated expression plasmids encoding enhanced green fluorescence protein (EGFP) concatenated to the NH2 terminus of wild-type or mutant human type IIc Na-Pi cotransporter (NaPi-IIc), i.e., EGFP-hNaPi-IIc, EGFP-[M137]hNaPi-IIc, or EGFP-[Stop446]hNaPi-IIc. The V446Stop mutant showed complete loss of expression and function when assayed for apical patch expression in opossum kidney (OK) cells and sodium-dependent 33P uptake into Xenopus laevis oocytes. Conversely, EGFP-[M137]hNaPi-IIc was inserted into apical patches of OK cells and into oocyte membranes. However, when quantified by confocal microscopy, surface fluorescence was reduced to 40% compared with wild-type. After correction for surface expression, the rate of 33P uptake by oocytes mediated by EGFP-[M137]hNaPi-IIc was decreased by an additional 60%. The resulting overall reduction of function of this NaPi-IIc mutant to 16%, taken together with complete loss of expression and function of g.4225_50del(V446Stop), thus appears to be sufficient to explain the phenotype in our patient. Furthermore, the stoichiometric ratio of 22Na and 33P uptake was increased to 7.1 +/- 3.65 for EGFP-[M137]hNaPi-IIc compared with wild-type. Two-electrode studies indicate that EGFP-[M137]hNaPi-IIc is nonelectrogenic but displayed a significant phosphate-independent inward-rectified sodium current, which appears to be insensitive to phosphonoformic acid. M137 thus may uncouple sodium-phosphate cotransport, suggesting that this amino acid residue has an important functional role in human NaPi-IIc.
Bacconi,
Renouncing electroneutrality is not free of charge: switching on electrogenicity in a Na+-coupled phosphate cotransporter.
2005, Pubmed,
Xenbase
Bacconi,
Renouncing electroneutrality is not free of charge: switching on electrogenicity in a Na+-coupled phosphate cotransporter.
2005,
Pubmed
,
Xenbase
Bacic,
The renal Na+/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone.
2006,
Pubmed
Bacic,
Novel aspects in regulated expression of the renal type IIa Na/Pi-cotransporter.
2004,
Pubmed
Beck,
Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities.
1998,
Pubmed
Bergwitz,
SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis.
2006,
Pubmed
Bueno,
Functional characterization and visualization of a GABAA receptor-GFP chimera expressed in Xenopus oocytes.
1998,
Pubmed
,
Xenbase
Caverzasio,
Sodium-dependent phosphate transport inhibited by parathyroid hormone and cyclic AMP stimulation in an opossum kidney cell line.
1986,
Pubmed
Chen,
Hypercalciuric hypophosphatemic rickets, mineral balance, bone histomorphometry, and therapeutic implications of hypercalciuria.
1989,
Pubmed
Cole,
Clonal sublines that are morphologically and functionally distinct from parental OK cells.
1989,
Pubmed
Forster,
Stoichiometry and Na+ binding cooperativity of rat and flounder renal type II Na+-Pi cotransporters.
1999,
Pubmed
,
Xenbase
Hernando,
PDZ-domain interactions and apical expression of type IIa Na/P(i) cotransporters.
2002,
Pubmed
Hernando,
PTH-Induced downregulation of the type IIa Na/P(i)-cotransporter is independent of known endocytic motifs.
2000,
Pubmed
Ichikawa,
Intronic deletions in the SLC34A3 gene cause hereditary hypophosphatemic rickets with hypercalciuria.
2006,
Pubmed
Kong,
A high-resolution recombination map of the human genome.
2002,
Pubmed
Levi,
Novel NaPi-2c mutations that cause mistargeting of NaPi-2c protein and uncoupling of Na-Pi cotransport cause HHRH.
2008,
Pubmed
Lorenz-Depiereux,
Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3.
2006,
Pubmed
Madjdpour,
Segment-specific expression of sodium-phosphate cotransporters NaPi-IIa and -IIc and interacting proteins in mouse renal proximal tubules.
2004,
Pubmed
Miyamoto,
Physiological regulation of renal sodium-dependent phosphate cotransporters.
2004,
Pubmed
Miyamoto,
New aspect of renal phosphate reabsorption: the type IIc sodium-dependent phosphate transporter.
2007,
Pubmed
Murer,
The sodium phosphate cotransporter family SLC34.
2004,
Pubmed
Rüsch,
Classic benzodiazepines modulate the open-close equilibrium in alpha1beta2gamma2L gamma-aminobutyric acid type A receptors.
2005,
Pubmed
,
Xenbase
Segawa,
Npt2a and Npt2c in mice play distinct and synergistic roles in inorganic phosphate metabolism and skeletal development.
2009,
Pubmed
Segawa,
Internalization of renal type IIc Na-Pi cotransporter in response to a high-phosphate diet.
2005,
Pubmed
Segawa,
Growth-related renal type II Na/Pi cotransporter.
2002,
Pubmed
,
Xenbase
Segawa,
Parathyroid hormone-dependent endocytosis of renal type IIc Na-Pi cotransporter.
2007,
Pubmed
Tenenhouse,
Differential effects of Npt2a gene ablation and X-linked Hyp mutation on renal expression of Npt2c.
2003,
Pubmed
Tieder,
Hyperoxaluria is not a cause of nephrocalcinosis in phosphate-treated patients with hereditary hypophosphatemic rickets.
1993,
Pubmed
Tieder,
"Idiopathic" hypercalciuria and hereditary hypophosphatemic rickets. Two phenotypical expressions of a common genetic defect.
1987,
Pubmed
Tieder,
Hereditary hypophosphatemic rickets with hypercalciuria.
1985,
Pubmed
Villa-Bellosta,
Interactions of the growth-related, type IIc renal sodium/phosphate cotransporter with PDZ proteins.
2008,
Pubmed
